Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Creating Robust Digital Tools to Extend Participation in Clinical Trials with Alicia Staley Medidata
Jul 19, 2023
Alicia Staley is the VP of Patient Engagement at Medidata and working to bring more technology and software solutions to clinical research. With a focus on creating patient-centric clinical trials, Alicia emphasizes the value of digital tools to drive diversity of participation and retention. As a cancer survivor and patient advocate, Alicia has deep insights into how clinical trials are run and who participates.
Alicia explains, "I think the entire industry is still responding to what life looks like post-COVID. However, in particular, in clinical research, this gravitation toward more digital tools to support clinical research is still very much at the forefront. Topics like decentralized clinical trials and patient portals, patient registries, and ways to support the patient through the clinical journey using digital tools, sensors, and wearables are very much at the forefront of the conversations we're having today. Clearly there is an interest in going in that direction. And I think we learned during the pandemic that these tools are great resources for expanding the potential participation in clinical research to essentially a broader audience of participants."
"It took the pandemic for the industry to realize that these tools are valuable resources. I think there had been historically quite a bit of hesitancy to embrace technical solutions like eConsent, eCOA, ePRO, or any of the eSource tools. And I think the pandemic made us realize that these tools are here, they're here to stay, and they work very, very well. But our hand was never forced in the way it was during the pandemic."
#Medidata #DecentralizedTrials #Diversity #ClinicalTrials #LifeSciences #PatientExperience
